The Czech Republic & Slovakia Affiliate of ISPE was founded in 1999. In March the Committee was established and in September 1999 the Czech Republic & Slovakia Affiliate of ISPE came officially into existence.
The Czech Republic & Slovakia Affiliate of ISPE was founded in 1999. In March the Committee was established and in September 1999 the Czech Republic & Slovakia Affiliate of ISPE came officially into existence.
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline ICH
The 2024 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights...
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in
This course is focused on how to be compliant in the design, operation & qualification of critical utilities and how to prove it. It comprises four modules including...
Specifically targeted to the needs of facility projects within the regulated pharmaceutical industry and demonstrates the value inherent in the use of “good practice” project...
The 2024 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights...
2023-2025 We are pleased to share the 2023–2025 ISPE Strategic Plan video, which reflects an ongoing commitment to our mission and vision and outlines our priorities for the next three years. Hear from ISPE International...
This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply...
The commercialization of personalized medicine has ushered in demand for a new type of facility—personalized medicine facilities—which can produce thousands of small-scale batches per year. There are currently only a handful of these sites, but...